Anti Inflammatory Drugs Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 5.63 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
| Market Concentration | Low |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Anti Inflammatory Drugs Market Analysis
Anti-inflammatory drugs are the drugs that are used to treat conditions like Asthma, Arthritis, Chronic obstructive pulmonary disease (COPD) and other diseases. Increasing prevalence of these diseases is the major factor propelling the market upwards. Although documented incidences of side effects and patent expiration of Blockbuster drugs are restraining the market growth, new research advancements in Anti Inflammatory Biologics, Immune Selective Anti-Inflammatory Derivatives (ImSAIDs), etc. are helping to make this class of drugs as side effect free as possible, maintaining the efficacy and potency of the drug.
Moreover, increasing awareness of anti-inflammatory therapeutics and attractive government initiatives are expected to drive the overall market.
Anti Inflammatory Drugs Market Trends
This section covers the major market trends shaping the Anti Inflammatory Drugs Market according to our research experts:
Anti Inflammatory Drugs for Arthritis Treatment is Found Dominating the Market
Arthritis is the inflammation in the joints. There are different types of arthritis, osteoarthritis and rheumatoid arthritis being most common among them. Arthritis is found to be more prevalent in the geriatric population, but there have been some documented cases of arthritis in children as well. Other common forms of arthritis include psoriatic arthritis, fibromyalgia and gout.
Osteoarthritis is caused due to the breakdown of protective cartilage, causing pain and movement of joints difficult. Non-steroidal Anti-Inflammatory drugs (NSAIDs) like diclofenac, ibuprofen and naproxen have been proven to be very effective in suppressing the pain from Osteoarthritis but may cause side effects like stomach upset, cardiovascular problems, bleeding problems, and liver and kidney damage. NSAID gels have also been proven to alleviate the pain and have lesser side effects. Doctors have been turning towards prescribing newest form of Anti-Inflammation drugs called Biologics.
The risk of arthritis has only increased in recent times due to an increase in the sedentary lifestyle, obesity, and unhealthy food habits. Hence, the drug market for its treatment will only see growth in recent future.
North America is Expected to Dominate the Anti-Inflammatory Drugs Market
North America is the largest market in the Anti-Inflammatory Drugs Market due to the factors such as established healthcare sector with a large number of renowned players, high investment & demand for more effective and safer drugs, etc. Moreover, the high income per capita, rise in patient visits to physicians, research advancements due to high funding are some of the factors that are driving the growth of the North American market.
However, Asia Pacific is expected to emerge as the fastest market, driven by a vast patient pool, increasing disposable incomes, growth in healthcare spending, and rising awareness about health.
Anti Inflammatory Drugs Industry Overview
Majority of the Anti-Inflammatory drugs are being manufactured by the global key players. Market leaders with more funds for research and better distribution system have established their position in the market.
Anti Inflammatory Drugs Market Leaders
-
Amgen Inc
-
Sun Pharmaceutical Industries Ltd
-
Johnson & Johnson
-
Pfizer Inc.
-
Novartis AG
*Disclaimer: Major Players sorted in no particular order
Anti Inflammatory Drugs Market Report - Table of Contents
-
1. INTRODUCTION
-
1.1 Study Deliverables
-
1.2 Study Assumptions
-
1.3 Scope of the Study
-
-
2. RESEARCH METHODOLOGY
-
3. EXECUTIVE SUMMARY
-
4. MARKET DYNAMICS
-
4.1 Market Overview
-
4.2 Market Drivers
-
4.2.1 Rising Incidences of Autoimmnue and Respiratory Conditions
-
4.2.2 Growing Research for Safer New Anti-Inflammatory Drugs
-
-
4.3 Market Restraints
-
4.3.1 Side Effects of Anti-Inflammtory Drugs
-
4.3.2 Patent Expiration
-
-
4.4 Porter's Five Force Analysis
-
4.4.1 Threat of New Entrants
-
4.4.2 Bargaining Power of Buyers/Consumers
-
4.4.3 Bargaining Power of Suppliers
-
4.4.4 Threat of Substitute Products
-
4.4.5 Intensity of Competitive Rivalry
-
-
-
5. MARKET SEGMENTATION
-
5.1 By Treatment
-
5.1.1 Arthritis
-
5.1.2 Chronic obstructive pulmonary disease (COPD)
-
5.1.3 Multiple Sclerosis
-
5.1.4 Inflammatory bowel disease (IBD)
-
5.1.5 Asthma
-
5.1.6 Tendonitis
-
5.1.7 Other Treatments
-
-
5.2 By Drug Class
-
5.2.1 Anti-Inflammatory Biologics
-
5.2.2 Nonsteroidal anti inflammatory drugs (NSAIDS)
-
5.2.3 Corticosteroids
-
5.2.4 Immune-selective anti-inflammatory derivative (ImSAID)
-
5.2.5 Other Drug Classes
-
-
5.3 By Sales Channel
-
5.3.1 Prescription
-
5.3.2 Over the Counter (OTC)
-
-
5.4 Geography
-
5.4.1 North America
-
5.4.1.1 United States
-
5.4.1.2 Canada
-
5.4.1.3 Mexico
-
-
5.4.2 Europe
-
5.4.2.1 Germany
-
5.4.2.2 United Kingdom
-
5.4.2.3 France
-
5.4.2.4 Italy
-
5.4.2.5 Spain
-
5.4.2.6 Rest of Europe
-
-
5.4.3 Asia Pacific
-
5.4.3.1 China
-
5.4.3.2 Japan
-
5.4.3.3 India
-
5.4.3.4 Australia
-
5.4.3.5 South Korea
-
5.4.3.6 Rest of Asia-Pacific
-
-
5.4.4 Middle East and Africa
-
5.4.4.1 GCC
-
5.4.4.2 South Africa
-
5.4.4.3 Rest of Middle East and Africa
-
-
5.4.5 South America
-
5.4.5.1 Brazil
-
5.4.5.2 Argentina
-
5.4.5.3 Rest of South America
-
-
-
-
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
-
6.1.1 Pfizer Inc.
-
6.1.2 Amgen Inc.
-
6.1.3 GlaxoSmithKline PLC
-
6.1.4 Johnson & Johnson
-
6.1.5 Novartis AG
-
6.1.6 F. Hoffmann-La Roche AG
-
6.1.7 AbbVie Inc
-
6.1.8 AstraZeneca PLC
-
6.1.9 Merck & Company, Inc.
-
6.1.10 Eli Lily and Company
-
- *List Not Exhaustive
-
-
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Anti Inflammatory Drugs Industry Segmentation
As per the scope of the report, anti-inflammatory drugs help suppress the inadvertent alarm, the immune system triggers against body cells, which causes inflammation in the various body part. With increasing sedentary lifestyle and deteriorating air quality in many parts of the world, the prevalence of arthritis and respiratory related diseases are on the rise. Hence, there has been an increase in the Anti-inflammatory drugs market in the past decade, and the trend seems to only increase with a much healthier rate.
| By Treatment | |
| Arthritis | |
| Chronic obstructive pulmonary disease (COPD) | |
| Multiple Sclerosis | |
| Inflammatory bowel disease (IBD) | |
| Asthma | |
| Tendonitis | |
| Other Treatments |
| By Drug Class | |
| Anti-Inflammatory Biologics | |
| Nonsteroidal anti inflammatory drugs (NSAIDS) | |
| Corticosteroids | |
| Immune-selective anti-inflammatory derivative (ImSAID) | |
| Other Drug Classes |
| By Sales Channel | |
| Prescription | |
| Over the Counter (OTC) |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Anti Inflammatory Drugs Market Research FAQs
What is the current Anti Inflammatory Drugs Market size?
The Anti Inflammatory Drugs Market is projected to register a CAGR of 5.63% during the forecast period (2024-2029)
Who are the key players in Anti Inflammatory Drugs Market?
Amgen Inc, Sun Pharmaceutical Industries Ltd, Johnson & Johnson, Pfizer Inc. and Novartis AG are the major companies operating in the Anti Inflammatory Drugs Market.
Which is the fastest growing region in Anti Inflammatory Drugs Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Anti Inflammatory Drugs Market?
In 2024, the North America accounts for the largest market share in Anti Inflammatory Drugs Market.
What years does this Anti Inflammatory Drugs Market cover?
The report covers the Anti Inflammatory Drugs Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Anti Inflammatory Drugs Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Anti-inflammatory Drugs Industry Report
Statistics for the 2024 Anti-inflammatory Drugs market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Anti-inflammatory Drugs analysis includes a market forecast outlook 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
